Pharmacy Times Office of Continuing Education, LLC – Trademark Portfolio
Entity Type: 16
Pharmacy Times Office of Continuing Education, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 5 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include PHARMSKILLS, POWERED BY PATIENTS, PATIENT JOURNEYS FOR CHANGE, and ONCOLOGY PHARMACISTS CONNECT. The owner is based in Cranbury, NJ.
2 Clarke Drive
Cranbury, NJ 08512
Showing of trademarks Trademarks
Trademark Classifications
Pharmacy Times Office of Continuing Education, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Pharmacy Times Office of Continuing Education, LLC have?
Pharmacy Times Office of Continuing Education, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.
What trademark classes does Pharmacy Times Office of Continuing Education, LLC file in?
Pharmacy Times Office of Continuing Education, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 41 (Education & Entertainment). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Pharmacy Times Office of Continuing Education, LLC's most well-known trademarks?
Pharmacy Times Office of Continuing Education, LLC's registered trademark portfolio includes well-known marks such as PHARMSKILLS, POWERED BY PATIENTS, PATIENT JOURNEYS FOR CHANGE, and ONCOLOGY PHARMACISTS CONNECT. These are among 4 currently registered trademarks in the portfolio.
What is Pharmacy Times Office of Continuing Education, LLC's trademark registration success rate?
Pharmacy Times Office of Continuing Education, LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.